Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials ; volume:13 ; number:1 ; day:16 ; month:9 ; year:2013 ; pages:1-11 ; date:12.2013
BMC infectious diseases ; 13, Heft 1 (16.9.2013), 1-11, 12.2013
- Creator
-
Launay, Odile
- Contributor
-
Duval, Xavier
Fitoussi, Serge
Jilg, Wolfgang
Kerdpanich, Angkool
Montellano, May
Schwarz, Tino F.
Watanveerade, Veerachai
Wenzel, Jürgen J.
Zalcman, Gerard
Bambure, Vinod
Li, Ping
Caplanusi, Adrian
Madan, Anuradha
Gillard, Paul
Vaughn, David W.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-13-435
- URN
-
urn:nbn:de:1111-201603035514
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Launay, Odile
- Duval, Xavier
- Fitoussi, Serge
- Jilg, Wolfgang
- Kerdpanich, Angkool
- Montellano, May
- Schwarz, Tino F.
- Watanveerade, Veerachai
- Wenzel, Jürgen J.
- Zalcman, Gerard
- Bambure, Vinod
- Li, Ping
- Caplanusi, Adrian
- Madan, Anuradha
- Gillard, Paul
- Vaughn, David W.
- SpringerLink (Online service)
Other Objects (12)
Adjuvanted (AS03) A/H1N1 2009 Pandemic Influenza Vaccines and Solid Organ Transplant Rejection: Systematic Signal Evaluation and Lessons Learnt
Mastoparan-7 adjuvanted COBRA H1 and H3 hemagglutinin influenza vaccines
Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection
Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial
Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design
Humoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employees
Responses to pandemic ASO3-adjuvanted A/California/07/09 H1N1 influenza vaccine in human immunodeficiency virus-infected individuals
Adjuvanted infuenza vaccine dynamics
Adjuvanted influenza vaccine dynamics
Safety and efficacy of C. muridarum vaccines adjuvanted with CpG-1826 and four concentrations of Montanide-ISA-720-VG
Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model
Enhanced immune response after a second dose of an AS03-adjuvanted H1N1 influenza A vaccine in patients after hematopoietic stem cell transplantation
Adjuvanted (AS03) A/H1N1 2009 Pandemic Influenza Vaccines and Solid Organ Transplant Rejection: Systematic Signal Evaluation and Lessons Learnt
Mastoparan-7 adjuvanted COBRA H1 and H3 hemagglutinin influenza vaccines
Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection
Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial
Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design
Humoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employees
Responses to pandemic ASO3-adjuvanted A/California/07/09 H1N1 influenza vaccine in human immunodeficiency virus-infected individuals
Adjuvanted infuenza vaccine dynamics
Adjuvanted influenza vaccine dynamics
Safety and efficacy of C. muridarum vaccines adjuvanted with CpG-1826 and four concentrations of Montanide-ISA-720-VG
Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model
Enhanced immune response after a second dose of an AS03-adjuvanted H1N1 influenza A vaccine in patients after hematopoietic stem cell transplantation
Adjuvanted (AS03) A/H1N1 2009 Pandemic Influenza Vaccines and Solid Organ Transplant Rejection: Systematic Signal Evaluation and Lessons Learnt
Mastoparan-7 adjuvanted COBRA H1 and H3 hemagglutinin influenza vaccines
Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection
Immunogenicity of adjuvanted versus high-dose inactivated influenza vaccines in older adults: a randomized clinical trial
Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design
Humoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employees
Responses to pandemic ASO3-adjuvanted A/California/07/09 H1N1 influenza vaccine in human immunodeficiency virus-infected individuals
Adjuvanted infuenza vaccine dynamics
Adjuvanted influenza vaccine dynamics
Safety and efficacy of C. muridarum vaccines adjuvanted with CpG-1826 and four concentrations of Montanide-ISA-720-VG
Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model